v3.26.1
SEGMENT REPORTING (Tables)
12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of segment information
                       
    Year Ended December 31, 2025  
    Biotechnology Segment     Technology
Segment
    Consolidated  
Sales   $     $ 1,363,045     $ 1,363,045  
Cost of goods sold           180,625       180,625  
Total operating expenses     13,540,971       684,947       14,225,918  
Net (loss) gain from operations   $ (13,540,971 )   $ 497,473     $ (13,043,498 )

 

    Year Ended December 31, 2024  
    Biotechnology Segment     Technology
Segment
    Consolidated  
Sales   $     $     $  
Cost of goods sold                  
Total operating expenses     10,054,488             10,054,488  
Net loss from operations   $ (10,054,488 )   $     $ (10,054,488 )